1. CP-199 Effectiveness and safety of eculizumab in atypical haemolytic uraemic syndrome and thrombotic microangiopathy. (14th February 2016) Authors: Gómez-Álvarez, S; Llopis-Salvia, P; Avila-Bernabeu, A; Pallardó-Mateu, L; Climente-Martí, M Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0704-HPR PATIENT ACTIVATION AND ADHERENCE TO BIOLOGICAL THERAPY AND TARGETED SYNTHETIC DMARD: PRELIMINARY RESULTS:. (June 2019) Authors: Sendra-García, A; Llopis-Salvia, P; Hermenegildo-Caudevilla, Marta; Aguilar-Zamora, Marta; Montolio-Chiva, L; Orenes Vera, Ana Victoria; Vázquez-Gómez, I; Martínez-Ferrer, À; Ybáñez-García, D; Valls-Pascual, Elia; Núñez-Monje, V; Torner-Hernández, I; Climente-Martí, Mónica; Alegre-Sancho, Juanjo J Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗